Immix Biopharma appointed Richard Graydon as Chief Medical Officer in March 2026, but he was terminated in July after it was revealed he was actually Ronald L. Fischer, a fugitive wanted since 2005 for rape charges. This revelation led to a 14.15% drop in Immix's stock price. Pomerantz LLP is investigating whether the company and its officers engaged in securities fraud or other unlawful practices. Investors affected are encouraged to contact the law firm for potential class action participation.
An Amazon cargo plane operated by 21 Air overran the runway at Miami International Airport on Sept. 6, 2026, crashing into vehicles and killing at least five people while injuring five others. The Boeing 767-300, arriving from San Juan, Puerto Rico, ...
XLM crypto price rose 1.45% to approach the key $0.20 level, extending recovery from August lows near $0.155. Stellar recently integrated Tether's USDT0 stablecoin, enhancing liquidity and payment options on its network. This addition aims to increas...
Kamino Finance has launched a new borrowing market on the Solana blockchain that allows users to use bridged Zcash (ZEC) as collateral to borrow USDC stablecoins. This move expands Kamino's lending platform into non-native and privacy-focused assets,...
Crude oil prices surged to their highest in six weeks due to renewed US-Iran conflicts and attacks on Saudi Aramco facilities, raising concerns over Middle East energy supplies. Brent crude reached $97.73 per barrel, and US West Texas Intermediate hi...
The Invesco QQQ Trust ETF charged a steady 0.20% fee for years due to its unit investment trust structure, even as cheaper rivals emerged. This fee only decreased after shareholders approved a reclassification to an open-end fund structure at the end...
